Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046
Titel:
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046
Auteur:
Krajnak, Slavomir Decker, Thomas Schollenberger, Lukas Rosé, Christian Ruckes, Christian Fehm, Tanja Thomssen, Christoph Harbeck, Nadia Schmidt, Marcus